News
-
-
-
COMMUNIQUÉ DE PRESSE
Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine
Transgene expands myvac® into Non-Small Cell Lung Cancer with TG4070, an individualized neoantigen therapeutic vaccine. New randomized Phase 1 trial in NSCLC announced, combining innovative technologies for faster vaccine supply -
-
-
COMMUNIQUÉ DE PRESSE
Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases
Transgene to present preclinical data on novel TG-MVA prophylactic vaccine against mpox at World Congress on Infectious Diseases. Focus on Orthopoxvirus-related diseases. Oral presentation by Head of Vectorology Laboratory, Nathalie Silvestre -
-
-
-
